Business

Buffalo Bills and OPKO Health's BioReference Laboratories Initiate the First Large Scale, Mandatory COVID-19 Fan Testing Program

The Bills leverage testing capabilities from NFL testing provider, BioReference, to initiate fan testing program ORCHARD PARK, N.Y., Dec. 31, 2020

articleOpko Health, Inc.December 31, 20204/company/opko-health-inc/news/buffalo-bills-and-opko-healths-bioreference-laboratories-initiate-the-first-large
Buffalo Bills and OPKO Health's BioReference Laboratories Initiate the First Large Scale, Mandatory COVID-19 Fan Testing Program

About this update from Opko Health, Inc.

[{"type":"text","content":"The Bills leverage testing capabilities from NFL testing provider, BioReference, to initiate fan testing program\n\n\nORCHARD PARK, N.Y., Dec. 31, 2020 /PRNewswire/ -- Buffalo Bills, 2020 AFC East Division Champions, and BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced they will be performing fan testing for the AFC Divisional Wild Card playoff game at Bills Stadium in Orchard Park. \n\n \n \n \n \n \n \n\n \nThrough New York State, the Bills have been granted permission to host fans at their home Wild Card game that will be played on Jan. 9 or 10. All fans will be required to obtain a negative COVID-19 PCR laboratory-based test result within 72 hours of the game through the NFL's testing partner, BioReference, in order to attend the game. Fans that purchase a ticket will be given a BioReference URL to select a testing time at Bills Stadium, two or three days prior to game day. \n\"BioReference has been helping our players, coaches and staff stay safe all season,\" said Kim Pegula, Bills Owner and President. \"We have no doubt they will help create a safe environment for our long awaited home playoff game. We are pleased to expand our partnership to bring fans back into the stadium.\" \n\"The Bills, New York State and BioReference are committed to providing a safe environment so that fans can enjoy the playoff game,\" said Jon R. Cohen, M.D., Executive Chairman of BioReference Laboratories. \"BioReference has led the way in providing customized large scale COVID-19 screening programs to organizations and municipalities across the country. Fan testing is the next natural step in helping Americans attend and enjoy live sporting and entertainment events.\" \n\"Bills fans have waited decades in order to attend a home playoff game and we have worked to build an innovative pilot program to make that happen safely,\" Governor Cuomo said. \"All season long, the Bills' stellar play has captured a certain energy and charisma that is undoubtedly infectious, but we all need to be smart. We're in control of our destiny and how we act is going to determine what comes next. So while this is a time for excitement and celebration, it's critical that everyone follow the guidelines and practice the safe behaviors we know work. If everyone does their part, I believe this pilot will be successful. Go Bills!\" \nA...

More updates from Opko Health, Inc.